Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,578

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

Roberts, Devender, Dalziel, Stuart R · 2006 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Respiratory distress syndrome (RDS) is a serious complication of preterm birth and the primary cause of early neonatal mortality and disability. OBJECTIVES: To assess the effects on fetal and neonatal morbidity and mortality, on maternal mortality and morbidity, and on the child in later life of administering corticosteroids to the mother before anticipated preterm birth. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group Trials Register (30 October 2005). SELECTION CRITERIA: Randomised controlled comparisons of antenatal corticosteroid administration (betamethasone, dexamethasone, or hydrocortisone) with placebo or with no treatment given to women with a singleton or multiple pregnancy, expected to deliver preterm as a result of either spontaneous preterm labour, preterm prelabour rupture of the membranes or elective preterm delivery. DATA COLLECTION AND ANALYSIS: Two review authors assessed trial quality and extracted data independently. MAIN RESULTS: Twenty-one studies (3885 women and 4269 infants) are included. Treatment with antenatal corticosteroids does not increase risk to the mother of death, chorioamnionitis or puerperal sepsis. Treatment with antenatal corticosteroids is associated with an overall reduction in neonatal death (relative risk (RR) 0.69, 95% confidence interval (CI) 0.58 to 0.81, 18 studies, 3956 infants), RDS (RR 0.66, 95% CI 0.59 to 0.73, 21 studies, 4038 infants), cerebroventricular haemorrhage (RR 0.54, 95% CI 0.43 to 0.69, 13 studies, 2872 infants), necrotising enterocolitis (RR 0.46, 95% CI 0.29 to 0.74, eight studies, 1675 infants), respiratory support, intensive care admissions (RR 0.80, 95% CI 0.65 to 0.99, two studies, 277 infants) and systemic infections in the first 48 hours of life (RR 0.56, 95% CI 0.38 to 0.85, five studies, 1319 infants). Antenatal corticosteroid use is effective in women with premature rupture of membranes and pregnancy related hypertension syndromes. AUTHORS' CONCLUSIONS: The evidence from this new review supports the continued use of a single course of antenatal corticosteroids to accelerate fetal lung maturation in women at risk of preterm birth. A single course of antenatal corticosteroids should be considered routine for preterm delivery with few exceptions. Further information is required concerning optimal dose to delivery interval, optimal corticosteroid to use, effects in multiple pregnancies, and to confirm the long-term effects into adulthood.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd004454.pub2

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 29

  1. 1984, Effect of antenatal dexamethasone administration in the infant: long term follow-up, Journal of Pediatrics, 105, 259
  2. Zachman, 1982, The NIH multicenter study and miscellaneous clinical trials of antenatal corticosteroid administration, II, 275
  3. Garite, 1993, A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24-28 weeks gestation, Surgery, Gynecology and Obstetrics, 176, 37
  4. Kari, 1994, Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomised placebo-controlled multicenter study, Pediatrics, 93, 730
  5. Howie, 1986, Pharmacological acceleration of lung maturation, 385
  6. Howie, 1977, Clinical trial of antepartum betamethasone therapy for prevention of respiratory distress in pre-term infants, 281
  7. Howie, 1973, Prevention of respiratory distress syndrome in premature infants by antepartum glucocorticoid treatment, 369
  8. Howie, 1982, The New Zealand study of antepartum glucocorticoid treatment, 255
  9. Liggins, 1974, Prevention of respiratory distress syndrome by maternal steroid therapy, 415
  10. MacArthur, 1989, Long term follow up of children exposed to betamethasone in utero, 81
  11. Sobel, 1988, Antenatal antibiotics in PROM prevents congenital bacterial infection, Pediatric Research, 23, 476A
  12. Dessens, 1998, Twenty year follow up in antenatally corticosteroid-treated subjects, Prenatal and Neonatal Medicine, 3 Suppl 1, 32
  13. Schutte, 1979, The clinical use of corticosteroids for the acceleration of fetal lung maturity, Nederlands Tijdschrift voor Geneeskunde, 123, 420
  14. Abuhamad, 1999, The combined use of corticosteroids and thyrotropin releasing hormone in pregnancies with preterm rupture of membranes: a randomised double blind controlled trial, American Journal of Obstetrics and Gynecology, 180, S96
  15. Butterfill, 1979, Follow-up study of babies exposed to betamethasone before birth, Archives of Disease in Childhood, 54, 725
  16. Egerman, 1998, A randomized controlled trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome, Acta Obstetricia et Gynecologica Scandinavica, 178, S19
  17. Egerman, 1998, A comparison between oral and intramuscular dexamethasone in suppressing unconjugated estriol levels during the third trimester, American Journal of Obstetrics and Gynecology, 178, S182
  18. Kuhn, 1982, Betamethasone, albuterol and threatened premature delivery, Obstetrics & Gynecology, 60, 403
  19. Minoui, 1996, Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labor a randomized study, Prenatal and Neonatal Medicine, 1 Suppl 1, 156
  20. Morrison, 1981, Effect of corticosteroids and fetomaternal disorders on the L:S ratio, Surgery, Gynecology and Obstetrics, 153, 464
  21. Rotmensch, 1998, The effects of betamethasone versus dexamethasone on computer-analysed fetal heart rate characteristics: a prospective randomized trial, American Journal of Obstetrics and Gynecology, 178, S185
  22. Asnafei N Pourreza R Miri SM Pregnancy outcome in premature delivery of between 34-37 weeks and the effects of corticosteroid on it Journal of the Gorgan University of Medical Sciences 2004
  23. Dalziel, 2004, Long-term effects of antenatal exposure to betamethasone: thirty year follow-up of a randomised controlled trial [abstract], Pediatric Research, 55 Suppl, 101
  24. Barker, 1998, Mothers, babies and health in later life
  25. Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005 In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd
  26. Higgins JPT Green S Cochrane Reviewers' Handbook 4.2.5 [updated May 2005]; Section 6 In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd
  27. Liggins, 1972, A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants, Pediatrics, 50, 515, 10.1542/peds.50.4.515 · DOI · Paper page
  28. 1994, Effect of corticosteroids for fetal maturation on perinatal outcomes, American Journal of Obstetrics and Gynecology, 173, 246
  29. The Cochrane Collaboration Review Manager (RevMan) 2000

Cited by

See all 1,578

Metadata

Authors
Roberts, D., & Dalziel, S. R.
Venue
Cochrane Database of Systematic Reviews
Published
2006-07-19
Issue
3
Pages
CD004454-CD004454
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4256255843
Cited by
1,578
References
90
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.